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Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, IranAbstractCurrently some parasitic and viral infections, tuberculosis, brucellosis and hospital-acquired infections are challenging issues in Iran. Despite
decreasing the rate of some infectious diseases in Iran in recent years, improved sanitation, active surveillance, comprehensive infection
control strategies and monitoring appropriate use of antibiotics are indispensable.
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E-mail: darban.d@iums.ac.irInfectious diseases still cause death worldwide, especially in
developing countries. Over the past decades the incidence of in-
fectious diseases, particularly parasitic ones, has decreased signifi-
cantly in Iran. Shifting in the causes of death from infectious diseases
to noncommunicable diseases shows the success of improved
sanitary measures and effective national surveillance. However,
cutaneous leishmaniasis, hepatitis B virus (HBV), hepatitis C virus
(HCV), human immunodeficiency virus (HIV), tuberculosis (TB),
brucellosis and hospital-acquired infections are still challenging is-
sues [1]. In the case of viral infections, the infections caused byHIV,
HBV, HCV and recently Crimean-Congo haemorrhagic fever virus
are the most important infections, and gastrointestinal and respi-
ratory infections are the most common infections.
Despite a dramatic decline in its prevalence, HBV remains
the main cause of acute hepatitis in adults [1]. In recent years,
for sociocultural reasons, the rate of HIV has increased in Iran,
and currently the number of HIV-infected people is estimated
to be almost 110 000. According to the most recent reports,
HIV is commonly transmitted by injection (67%) and sexual
contact (18%) (http://aids.ir/Info) [2]. During the past two de-
cades an increased rate of Crimean-Congo haemorrhagic fever
has been reported from almost all parts of Iran. The virus isThis is an open access artioften transmitted by ticks, and less commonly through close
contact with infected patients [1,3]. In parasitic infections,
echinococcosis and cutaneous leishmaniasis are endemic in-
fections, but malaria is in the preelimination phase [3]. Although
TB is one of the most important diseases in developing coun-
tries, great success has been achieved in decreasing the TB
prevalence from 40 to 14 cases per 100 000 population in Iran
in the past 50 years.
The incidence of multidrug-resistant TB varies from 1.3% to
8.3% for new cases and previously treated cases, respectively
[4]. The reasons for this success in controlling TB are mainly
the launching of nine regional laboratories of TB as well as
improvements in diagnosis and treatment. Because of the
increasing incidence of immunodeficiency diseases such as
AIDS, and as a result of the significant improvements in labo-
ratory diagnostic methods in recent years, diseases caused by
nontuberculous mycobacteria such as Mycobacterium simiae,
Mycobacterium fortuitum, Mycobacterium kansasii and Mycobac-
terium intracellulare are rising [5]. Despite a substantial decline in
the incidence of human brucellosis in the past decades,
brucellosis remains endemic in all parts of Iran. Moreover,
plague, leptospirosis, tularaemia and Q fever are some of the
emerging and reemerging bacterial infections.
The most common hospital-acquired infections in Iran are
urinary tract infections, pneumonia, and surgical site and
bloodstream infections [1,3]. In recent years, as a result of the
overuse and/or inappropriate prescribing of antibiotics, there
has been a dramatic increase in the emergence of antibiotic-
resistant bacterial strains. Resistance to colistin, the last-New Microbe and New Infect 2019; 27: 7–8
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tant Gram-negative bacteria, has recently been detected among
the clinical isolates of Klebsiella pneumoniae [6]. Furthermore,
some Gram-positive cocci (staphylococci and enterococci)
have developed resistance to critical antibiotics so that the
prevalence of methicillin-resistant Staphylococcus aureus and
vancomycin-resistant enterococci have been found to be 43%
and 9.4% respectively [7,8], and there are some reports on
vancomycin-resistant S. aureus [9].
Despite a substantial reduction in the rate of some infectious
diseases in Iran in recent years, we need improved sanitation as
well as better active surveillance systems and comprehensive
infection control strategies. We also need to monitor the
appropriate use of antibiotics.
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